Gemphire Therapeutics (GEMP), NeuroBo Pharmaceuticals Announce Merger Agreement Jul 24, 2019 04:03PM
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company Jul 24, 2019 04:01PM
Gemphire Therapeutics (GEMP) Reports Top-Line Data from Familial Partial Lipodystrophy Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial Jun 26, 2019 08:03AM
Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial Jun 26, 2019 08:00AM
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results Mar 15, 2019 08:00AM


Dec 3, 2018 08:06AM Gemphire Therapeutics (GEMP) to Review Strategic Alternatives
Dec 3, 2018 08:00AM Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update
Sep 22, 2016 06:00AM Gemphire Therapeutics to Present Corporate Overview at the Ladenburg Thalmann 2016 Healthcare Conference